Eng
Sign In
Sign In / Sign Up

E-Poster

Introduction

E-Poster are electronic versions of posters that are usually presented in digital format, such as at conferences or exhibitions. They are similar to conventional posters in terms of content and purpose, but are presented in a digital format that allows for online sharing, with interactive features such as video, animation and hyperlinks. E-Poster can increase the attractiveness and interactivity of poster presentations, as well as allow users to easily share and store the information presented.

Guidelines for Writing E-Poster

E-Poster are uploaded via the website www.ilcbali2025.id. We do not accept revisions in any form after that date

  • 1E-Poster will be displayed on the LCD layer with the following conditions
    • Indonesian
    • Format: In JPG format (portrait orientation, 1 page)
    • Pixels: 19200 x 10805 pixels
    • Size: 165.56 x 91.48
    • Letters: Minimum size 16
    • File: 10-20 MB
    • Picture or table illustrations are informative and easy to understand
    • Does not support video or audio features
    • The color composition is harmonious and good
  • 2Research E-Poster and Case Reports must contain
    • Identification in the form of the names of the main and co-authors, as well as the institution of origin are included in full
    • The title is written in full capital letters
    • The research E-Poster consists of an Introduction / Background. Research Methods, Research Results, Discussion, Conclusions, and Bibliography / References
    • The case report E-Poster consists of an Introduction/Background, Case Report, Discussion, Conclusion, and Bibliography/References
  • 3The total number of bibliography on the E-poster is a maximum of 10 references
  • 4The presenter must bring a soft copy of the E-Poster

Submitted E-Poster

Author Title Action
Inge Nelissen Development of a nanoplasmonic assay for point-of-care detection and treatment monitoring of multibacillary leprosy View
Katharine Jones Population based Active-Case-Finding for leprosy – outcome of providing additional funding to five experienced partner organisations in four countries View
Charlotte John The current annual cost of providing health care to a person affected by leprosy – a crude estimate from 28 leprosy focused organisations in 12 countries View
APOORVA SHARMA BCG Vaccination and Leprosy: Assessing Protective Efficacy and Treatment Response View
Utpal Sengupta The Role of Soil-Transmitted Helminthic Parasite Infection in Developing Leprosy: A Cohort Study View
MONIKA BISWAS Towards Zero Leprosy and Discrimination: Climate-Adapted and Gender-Inclusive Advocacy for Bangladesh View
Mr. Krishna Prasad Subedi Nerve function impairment among new untreated leprosy patients at diagnosis and during Multidrug Therapy at Lalgadh Leprosy Hospital and Services Centre View
Faiqueen Dhia Salsabila Firlana Adnan Challenges in Managing Severe Type 2 Reaction in Child with Lepromatous Leprosy and Complications from Corticosteroid Abuse: A Case Report View
Laras Tobing Alternative multidrug therapy for lepromatous leprosy complicated by prolonged QT interval and liver injury: A case report View
SAMRUN NESSA Protocol: A Comparative Multicentric Non-Inferiority Trial of WHO MBMDT vs. Monthly Rifampicin, Moxifloxacin, Clarithromycin (RMC) in Multibacillary Leprosy patients. View